Clinical trial / 2013
Daily ingestion of 30 g of milled flaxseed significantly lowered systolic and diastolic blood pressure in peripheral artery disease patients over 6 months.
In a prospective, double-blinded, placebo-controlled trial, 110 patients with peripheral artery disease ingested foods containing 30 g of milled flaxseed or placebo daily for 6 months. Plasma α-linolenic acid and enterolignans increased 2- to 50-fold in the flaxseed group, with no significant differences in body weight between groups. After 6 months, SBP was ≈ 10 mm Hg lower and DBP was ≈ 7 mm Hg lower in the flaxseed group compared with placebo. In participants with baseline SBP ≥ 140 mm Hg, flaxseed led to a reduction of 15 mm Hg in SBP and 7 mm Hg in DBP, showing selective antihypertensive effects in hypertensive patients.
- Study type
- Prospective, double-blinded, placebo-controlled, randomized trial
- Who was studied
- 110 peripheral artery disease patients
- What was measured
- Systolic and diastolic blood pressure
THE PAPER
Potent antihypertensive action of dietary flaxseed in hypertensive patients.
Rodriguez-Leyva D, Weighell W, Edel AL, LaVallee R, Dibrov E, Pinneker R, Maddaford TG, Ramjiawan B, Aliani M, Guzman R, Pierce GN. Hypertension, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.